Drugs / oxycodone immediate-release
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00312221 | Apr 2004 → Jul 2005 | osteoarthritis | Purdue Pharma LP | Terminated | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oxycodone immediate-release | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00312221 ↗ |
| Route | Oral | “two 5-mg capsules every 6 hours” NCT00312221 ↗ |